Search

Your search keyword '"Kevin M, Hall"' showing total 3 results
Start Over Author "Kevin M, Hall" Publication Year Range Last 10 years
3 results on '"Kevin M, Hall"'

1. Platelet Dysfunction Diseases and Conditions: Clinical Implications and Considerations

Author

Amit Prabhakar, Kevin M. Hall, Matthew R. Watson, Elyse M. Cornett, John Thomas Wynn, Alan D. Kaye, Ceressa T. Ward, Vanessa Moll, Maxwell A. Hockstein, George M. Jeha, Ivan Urits, and Omar Viswanath

Subjects
medicine.medical_specialty, Platelet dysfunction, business.industry, Thrombotic thrombocytopenic purpura, General Medicine, medicine.disease, Rheumatology, Pathophysiology, Coagulation cascade, Internal medicine, Hemostasis, medicine, Etiology, Pharmacology (medical), Platelet, Intensive care medicine, business
Abstract

Platelet diseases and dysfunction are taught early in medical school to all future physicians. Understanding of the coagulation cascade and hemostatic mechanisms has allowed for targeted pharmacological therapies that have been significantly impactful in clinical practice. Platelets are an early participant in hemostasis physiologically and under pathophysiological states. A review of literature involving platelet disfunction. Various presentations of platelet diseases and dysfunction challenge clinicians and require a firm understanding of normal platelet function, drugs that mediate or modulate platelet effectiveness, and nonpharmacologic etiologies of platelet diseases and dysfunction with corresponding best practice treatment approaches. This review summarizes normal and abnormal states associated with platelets and treatment strategies.

Published
2020
Full Text
View/download PDF

2. Platelet Dysfunction Diseases and Conditions: Clinical Implications and Considerations

Author

Alan D, Kaye, George M, Jeha, Vanessa, Moll, Ceressa T, Ward, Matthew R, Watson, John Thomas, Wynn, Maxwell A, Hockstein, Kevin M, Hall, Omar, Viswanath, Ivan, Urits, Amit, Prabhakar, and Elyse M, Cornett

Subjects
Adult, Aged, 80 and over, Male, Hemostasis, Humans, Female, Blood Platelet Disorders, Middle Aged, Aged
Abstract

Platelet diseases and dysfunction are taught early in medical school to all future physicians. Understanding of the coagulation cascade and hemostatic mechanisms has allowed for targeted pharmacological therapies that have been significantly impactful in clinical practice. Platelets are an early participant in hemostasis physiologically and under pathophysiological states.A review of literature involving platelet disfunction.Various presentations of platelet diseases and dysfunction challenge clinicians and require a firm understanding of normal platelet function, drugs that mediate or modulate platelet effectiveness, and nonpharmacologic etiologies of platelet diseases and dysfunction with corresponding best practice treatment approaches.This review summarizes normal and abnormal states associated with platelets and treatment strategies.

Published
2020

3. Corticotrophins, corticosteroids, and prostaglandins

Author

Kevin M. Hall, Matthew R. Watson, and Marley L. Watson

Subjects
Corticotrophins, business.industry, respiratory system, Anesthesia, cardiovascular system, Medicine, lipids (amino acids, peptides, and proteins), business, PGE1 Analogue, Adverse effect, Misoprostol, hormones, hormone substitutes, and hormone antagonists, circulatory and respiratory physiology, Iloprost, medicine.drug, Treprostinil
Abstract

This is a review of current literature published between January 2018 and January 2019 including any publications regarding adverse effects related to corticotrophins, corticosteroids, and prostaglandins. The following medications are included: corticotrophins, glucocorticoids, and the following prostaglandins alprostadil (PGE1), epoprostenol (PGI1 analogue), iloprost (PGI2 analogue), misoprostol (PGE1 analogue), and treprostinil (PGI2 analogue).

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results